In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Dr. Vaia Florou
Advertisement
Articles by Dr. Vaia Florou
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CURE
1
Peritoneal Mesothelioma Survivor Shares Ongoing Reality of Survivorship
2
What Does a Stage 2 Prostate Cancer Diagnosis Mean for Me?
3
SUNRiSE-1 Participant Shares Insights on Bladder Cancer Education
4
Becoming Cancer-Aware: How My Diagnosis Changed the Way My Family Sees Everyday Products
5
